Published date: 29 November 2023

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 3 January 2024, 1pm

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£50,000,000

Procurement reference

CF-2037800D0O000000rwimUAA

Published date

29 November 2023

Closing date

3 January 2024

Closing time

1pm

Contract start date

1 March 2024

Contract end date

28 February 2025

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Project Title: NHS National Framework for Tocilizumab - March 2024

Offer reference number: CM/PHR/23/5702

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

More information

Attachments

Additional text

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk

About the buyer

Contact name

Katie Noonan

Address

Rutland House
Runcorn
WA7 2ES
GB

Email

katie.noonan@nhs.net